SYNACT — SynAct Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK743.42m
- SEK691.23m
Annual cashflow statement for SynAct Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -76.7 | -106 | -224 | -90 | -117 |
| Depreciation | |||||
| Non-Cash Items | 0.088 | -0.306 | 10.2 | 10.2 | 4.88 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.6 | -12.6 | 38.8 | -10 | 13.7 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -65 | -118 | -100 | -89.2 | -97.3 |
| Other Investing Cash Flow Items | -0.006 | 0.027 | 0.37 | 0 | — |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.006 | 0.027 | 0.37 | 0 | — |
| Financing Cash Flow Items | -5.6 | -27.3 | -4.75 | -6.14 | -1.18 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 74.3 | 201 | 54 | 87.4 | 90.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.45 | 84.2 | -45.9 | -1.19 | -7.8 |